Percutaneous coronary intervention

Transforming complex PCI procedures into confident care with Philips solutions

Integrate every step of the PCI procedure with advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services. All work intelligently together to efficiently support every step of coronary procedures, including PCI - from diagnosis to restoring vessel patency.

Demonstrated results

28.8%

reduction in contrast agent with Dynamic Coronary Roadmap2.

Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.

85%

of users believe the Azurion TSM control of HEMO visualizations & measurements improves workflow5.

$896

saved per patient with Philips iFR compared to FFR3.

Azurion with Flexvision

Azurion 7 M12 - the heart of our solution for cardiac care

Proven to reduce procedure time by 17%1 by experiencing the outstanding performance of the Azurion 7 M12. This industry-leading image-guided solution supports better patient care and operational efficiency with seamless control from a single tableside touch screen for fast, informed decisions in the sterile field.

Dynamic coronary roadmap

Dynamic Coronary Roadmap - find your path

Find the right path and improve PCI outcomes. This Philips exclusive solution offers motion-compensated, real-time navigational guidance of coronary arteries and reduces contrast agent by 28.8%²

Hemo wih IntelliVue X3

Hemo with IntelliVue X3 - monitor anywhere 

Improve productivity to meet growing demand for cath lab procedures. This solution simplifies workflow by bringing advanced hemodynamic measurements to the cath lab. Integrated with the IntelliVue X3 patient monitor, it enables continuous patient monitoring throughout the cath lab.

Physician using IntraSight

IntraSight

Philips IntraSight offers you a comprehensive suite of clinically proven6-10 imaging, physiology and co-registration11 tools on a modern, secure platform that will help you simplify complex interventions, speed routine procedures and improve lab efficiencies.

Technologies and innovations

  • Image-guided therapy

    Image-guided therapy solutions portfolio integrates best in class imaging systems and software, with diagnostic and therapeutic devices to support complex procedures.

  • Coronary IVUS - Intravascular Ultrasound

    Learn how Philips intravascular ultrasound (IVUS) imaging offers advanced visualization that enables you to tailor your treatment for every patient.

  • Clinically proven Azurion with ClarityIQ technology

    Providing superb image quality at ultra-low dose settings.

  • Azurion

    Philips Azurion is the next generation image-guided therapy platform with a unique user experience to help you optimize the performance of your cath lab.

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Footnotes
 

[1] Philips whitepaper 12nc 4522 991 30501; Reduction of procedure time by 17% with Philips Azurion in independently verified study; . Results are specific to the institution where they were obtained and may www.philips.com/ healthcare/resources/landing/azurion/lab-performance-study-results not reflect the results achievable at other institutions. 

[2] Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.

[3] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. 

[4] Co-registration tools available within InstraSight 7 configuration via SyncVision.

[5] Results obtained during usability study performed in December 2016. The study involved 33 participants. Participants were spread evenly over technologist/ nurses and physicians. To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by participants that had relevant working experience in the interventional lab and who had not previously used the new system. Data on File.

[6] Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017. 

[7] Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017. 

[8] Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.

[9] A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503. 

[10] Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing

[11] Co-registration tools available within IntraSight 7 configuration via SyncVision


Always read the label and follow the directions for use.Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.Products subject to country availability. Please contact your local sales representative.

©2024 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.